Kim C. M. van der Elst

Statistics

Publications

Citations

405

H-Index

Active since

2012

Affiliations

University Medical Center Groningen(Current)

University of Groningen

University Medical Center Utrecht

Utrecht University

Princess Máxima Center

Kim C. M. van der Elst is an author at University Medical Center Groningen specializing in pharmacology, pharmacokinetics of antifungal drugs, and antifungal pharmacotherapy.

ORCID

Publications per year

2012–2023

Publications

Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia

Linde Dekker, Friso Calkoen, Yilin Jiang et al. · Blood Advances · 2022 · 85 citations · Full text

Medicine, Hematology, Pharmacology +16

Dried Blood Spot Analysis Suitable for Therapeutic Drug Monitoring of Voriconazole, Fluconazole, and Posaconazole

Kim C. M. van der Elst, Lambert F. R. Span, Kai van Hateren et al. · Antimicrobial Agents and Chemotherapy · 2013 · 62 citations · Full text

Medicine, Infectious Diseases, Pharmacology +14

Low Caspofungin Exposure in Patients in Intensive Care Units

Kim C. M. van der Elst, Anette Veringa, Jan G. Zijlstra et al. · Antimicrobial Agents and Chemotherapy · 2016 · 59 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Insufficient Fluconazole Exposure in Pediatric Cancer Patients and the Need for Therapeutic Drug Monitoring in Critically Ill Children

Kim C. M. van der Elst, Marieke Pereboom, Edwin R. van den Heuvel et al. · Clinical Infectious Diseases · 2014 · 39 citations · Full text

Pharmacy, Pediatrics, Pharmacology +17

Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease

Kim C. M. van der Elst, Charlie H. S. Brouwers, Edwin R. van den Heuvel et al. · Therapeutic Drug Monitoring · 2015 · 32 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

1–5 of 12